Citadel Advisors
PCYC

Citadel Advisors’s PHARMACYCLICS INC PCYC Stock Holding History

Citadel Advisors’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,422,700
Closed -$364M – 9446
2015
Q1 		$364M Buy
1,422,700
+1,377,600
+3,055% +$266M 0.35% 22
2014
Q4 		$5.51M Sell
45,100
-42,500
-49% -$5.43M 0.01% 1890
2014
Q3 		$10.3M Sell
87,600
-12,700
-13% -$1.45M 0.01% 1344
2014
Q2 		$9M Buy
100,300
+28,900
+40% +$2.71M 0.01% 1359
2014
Q1 		$7.16M Sell
71,400
-15,800
-18% -$2.05M 0.01% 1501
2013
Q4 		$9.22M Sell
87,200
-254,400
-74% -$30.9M 0.01% 1253
2013
Q3 		$47.3M Buy
341,600
+318,200
+1,360% +$35.3M 0.07% 342
2013
Q2 		$1.86M Buy
+23,400
New +$1.91M ﹤0.01% 2564

Other funds holding PCYC

Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Citadel Advisors's PCYC Position: Q2 2015 in Review

Citadel Advisors sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 2,152 shares — an estimated $551K sold.

Citadel Advisors first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $16.6M in Q3 2014. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

  • Citadel Advisors reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
  • Citadel Advisors sold 2,152 PHARMACYCLICS INC shares in Q2 2015, an estimated $551K.
  • Citadel Advisors first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
  • Citadel Advisors's PHARMACYCLICS INC position peaked at $16.6M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on Citadel Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.